Anticancer agent 265
Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values of 13.1, 11.7, and 14.6 μM, respectively[1].
Product Specifications
CAS Number
[184177-83-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Purity
99.74
Smiles
O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C
Molecular Formula
C30H35N5O3
Molecular Weight
513.63
Precautions
H302, H315, H319, H335
References & Citations
[1]G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1- ((2S, 3S) -2- (benzyloxy) pentan-3-yl) -4- (4- (4- (4-hydroxyphenyl) piperazin-1-yl) phenyl) -1H-1, 2, 4-triazol-5 (4H) -one. Journal of Structural Chemistry 60.7 (2019) : 1173-1179.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
